365 related articles for article (PubMed ID: 16234230)
1. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
van Wassenaer AG; Westera J; Houtzager BA; Kok JH
Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
[TBL] [Abstract][Full Text] [Related]
2. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
3. Thyroid function in preterm newborns; is T4 treatment required in infants < 27 weeks' gestational age?
Van Wassenaer AG; Kok JH; Briët JM; van Baar AL; de Vijlder JJ
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():12-8. PubMed ID: 9439908
[TBL] [Abstract][Full Text] [Related]
4. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.
Briët JM; van Wassenaer AG; Dekker FW; de Vijlder JJ; van Baar A; Kok JH
Pediatrics; 2001 Apr; 107(4):712-8. PubMed ID: 11335749
[TBL] [Abstract][Full Text] [Related]
5. Increasing supplemental thyroid hormone use among premature infants born at 23 to 32 weeks' gestation.
Linn M; Yoder BA; Clark RH
Am J Perinatol; 2010 Oct; 27(9):731-5. PubMed ID: 20408110
[TBL] [Abstract][Full Text] [Related]
6. Functional outcome at school age of preterm infants with periventricular hemorrhagic infarction.
Roze E; Van Braeckel KN; van der Veere CN; Maathuis CG; Martijn A; Bos AF
Pediatrics; 2009 Jun; 123(6):1493-500. PubMed ID: 19482759
[TBL] [Abstract][Full Text] [Related]
7. Follow-up outcomes at 1 and 2 years of infants born less than 32 weeks after Newborn Individualized Developmental Care and Assessment Program.
Maguire CM; Walther FJ; van Zwieten PH; Le Cessie S; Wit JM; Veen S
Pediatrics; 2009 Apr; 123(4):1081-7. PubMed ID: 19336365
[TBL] [Abstract][Full Text] [Related]
8. Functioning at school age of moderately preterm children born at 32 to 36 weeks' gestational age.
van Baar AL; Vermaas J; Knots E; de Kleine MJ; Soons P
Pediatrics; 2009 Jul; 124(1):251-7. PubMed ID: 19564307
[TBL] [Abstract][Full Text] [Related]
9. Developmental follow-up of very low birthweight premature infants with low free thyroxine.
Karna P
Am J Perinatol; 1991 Jul; 8(4):288-91. PubMed ID: 1741876
[TBL] [Abstract][Full Text] [Related]
10. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants.
van Wassenaer AG; Briët JM; van Baar A; Smit BJ; Tamminga P; de Vijlder JJ; Kok JH
Pediatrics; 2002 Sep; 110(3):534-9. PubMed ID: 12205256
[TBL] [Abstract][Full Text] [Related]
11. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age.
Reuss ML; Paneth N; Pinto-Martin JA; Lorenz JM; Susser M
N Engl J Med; 1996 Mar; 334(13):821-7. PubMed ID: 8596548
[TBL] [Abstract][Full Text] [Related]
12. Outcome of infants born at 24-26 weeks' gestation: II. Neurodevelopmental outcome.
Piecuch RE; Leonard CH; Cooper BA; Kilpatrick SJ; Schlueter MA; Sola A
Obstet Gynecol; 1997 Nov; 90(5):809-14. PubMed ID: 9351769
[TBL] [Abstract][Full Text] [Related]
13. [Morbidity and mortality of extremely low gestational age infants in Schleswig-Holstein. Follow-up at three to six years corrected age of infants < 27 + 0 weeks gestation in Schleswig-Holstein, Germany].
Rapp M; Thyen U; Müller-Steinhardt K; Kohl M
Z Geburtshilfe Neonatol; 2005 Aug; 209(4):135-43. PubMed ID: 16138271
[TBL] [Abstract][Full Text] [Related]
14. Caregiver-reported health outcomes of preschool children born at 28 to 32 weeks' gestation.
Schiariti V; Houbè JS; Lisonkova S; Klassen AF; Lee SK
J Dev Behav Pediatr; 2007 Feb; 28(1):9-15. PubMed ID: 17353725
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997.
Mikkola K; Ritari N; Tommiska V; Salokorpi T; Lehtonen L; Tammela O; Pääkkönen L; Olsen P; Korkman M; Fellman V
Pediatrics; 2005 Dec; 116(6):1391-400. PubMed ID: 16322163
[TBL] [Abstract][Full Text] [Related]
16. Trials with thyroid hormone in preterm infants: clinical and neurodevelopmental effects.
van Wassenaer AG; Kok JH
Semin Perinatol; 2008 Dec; 32(6):423-30. PubMed ID: 19007681
[TBL] [Abstract][Full Text] [Related]
17. [Effects of early rehabilitative treatment on neurological development and cognitive and perceptual-motor functions of preterm infants at risk].
Pisaturo C; Contegno P; Sodini G
Minerva Pediatr; 1990; 42(7-8):281-9. PubMed ID: 1703265
[TBL] [Abstract][Full Text] [Related]
18. Improving head growth in preterm infants--a randomised controlled trial II: MRI and developmental outcomes in the first year.
Tan M; Abernethy L; Cooke R
Arch Dis Child Fetal Neonatal Ed; 2008 Sep; 93(5):F342-6. PubMed ID: 18285378
[TBL] [Abstract][Full Text] [Related]
19. Gestational age and birth weight in relation to school performance of 10-year-old children: a follow-up study of children born after 32 completed weeks.
Kirkegaard I; Obel C; Hedegaard M; Henriksen TB
Pediatrics; 2006 Oct; 118(4):1600-6. PubMed ID: 17015552
[TBL] [Abstract][Full Text] [Related]
20. The association of growth impairment with neurodevelopmental outcome at eight years of age in very preterm children.
Kan E; Roberts G; Anderson PJ; Doyle LW;
Early Hum Dev; 2008 Jun; 84(6):409-16. PubMed ID: 18096332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
